

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | low-density lipoprotein particle clearance (GO:0034383) | 8.98644028 |
| 2 | cellular response to ATP (GO:0071318) | 8.85276170 |
| 3 | regulation of sequestering of triglyceride (GO:0010889) | 8.03317709 |
| 4 | biotin metabolic process (GO:0006768) | 7.06129362 |
| 5 | behavioral response to nicotine (GO:0035095) | 6.67751733 |
| 6 | valine metabolic process (GO:0006573) | 6.55853236 |
| 7 | triglyceride catabolic process (GO:0019433) | 6.51547513 |
| 8 | meiotic chromosome segregation (GO:0045132) | 6.31609322 |
| 9 | white fat cell differentiation (GO:0050872) | 6.15023847 |
| 10 | regulation of cholesterol storage (GO:0010885) | 6.02895618 |
| 11 | GDP-mannose metabolic process (GO:0019673) | 5.90486410 |
| 12 | triglyceride biosynthetic process (GO:0019432) | 5.83766425 |
| 13 | neutral lipid catabolic process (GO:0046461) | 5.79400134 |
| 14 | acylglycerol catabolic process (GO:0046464) | 5.79400134 |
| 15 | brown fat cell differentiation (GO:0050873) | 5.59389614 |
| 16 | DNA strand renaturation (GO:0000733) | 5.55925002 |
| 17 | neutral lipid biosynthetic process (GO:0046460) | 5.42749927 |
| 18 | acylglycerol biosynthetic process (GO:0046463) | 5.42749927 |
| 19 | fatty acid transmembrane transport (GO:1902001) | 5.37054335 |
| 20 | positive regulation of protein kinase C signaling (GO:0090037) | 5.35565010 |
| 21 | acyl-CoA biosynthetic process (GO:0071616) | 5.33816792 |
| 22 | thioester biosynthetic process (GO:0035384) | 5.33816792 |
| 23 | rRNA methylation (GO:0031167) | 5.33221623 |
| 24 | purinergic nucleotide receptor signaling pathway (GO:0035590) | 5.28141611 |
| 25 | regulation of skeletal muscle contraction (GO:0014819) | 5.18177960 |
| 26 | fatty-acyl-CoA biosynthetic process (GO:0046949) | 5.12901241 |
| 27 | carnitine shuttle (GO:0006853) | 5.10516505 |
| 28 | negative regulation of cell aging (GO:0090344) | 5.09158024 |
| 29 | acetyl-CoA metabolic process (GO:0006084) | 5.04146004 |
| 30 | negative regulation of macrophage derived foam cell differentiation (GO:0010745) | 5.01389638 |
| 31 | lipid particle organization (GO:0034389) | 5.00564310 |
| 32 | long-chain fatty-acyl-CoA biosynthetic process (GO:0035338) | 4.94989196 |
| 33 | rRNA modification (GO:0000154) | 4.79658913 |
| 34 | glycerolipid catabolic process (GO:0046503) | 4.68324087 |
| 35 | nucleoside transmembrane transport (GO:1901642) | 4.65215101 |
| 36 | regulation of nuclear cell cycle DNA replication (GO:0033262) | 4.49321073 |
| 37 | urinary tract smooth muscle contraction (GO:0014848) | 4.46317559 |
| 38 | lipid storage (GO:0019915) | 4.44799925 |
| 39 | response to ATP (GO:0033198) | 4.44505100 |
| 40 | fatty-acyl-CoA metabolic process (GO:0035337) | 4.42549398 |
| 41 | negative regulation of lipid storage (GO:0010888) | 4.41012487 |
| 42 | branched-chain amino acid metabolic process (GO:0009081) | 4.40746448 |
| 43 | protoporphyrinogen IX metabolic process (GO:0046501) | 4.39698181 |
| 44 | long-chain fatty-acyl-CoA metabolic process (GO:0035336) | 4.39373510 |
| 45 | nucleotide transmembrane transport (GO:1901679) | 4.37960523 |
| 46 | heme biosynthetic process (GO:0006783) | 4.33705492 |
| 47 | branched-chain amino acid catabolic process (GO:0009083) | 4.21675330 |
| 48 | coenzyme A biosynthetic process (GO:0015937) | 4.16626051 |
| 49 | positive regulation of insulin receptor signaling pathway (GO:0046628) | 4.16534759 |
| 50 | fatty acid beta-oxidation (GO:0006635) | 4.13724869 |
| 51 | tRNA modification (GO:0006400) | 4.11885956 |
| 52 | positive regulation of lipid storage (GO:0010884) | 4.10662391 |
| 53 | positive regulation of cellular response to insulin stimulus (GO:1900078) | 4.07117526 |
| 54 | pentose-phosphate shunt (GO:0006098) | 4.04917288 |
| 55 | peristalsis (GO:0030432) | 4.00167105 |
| 56 | triglyceride metabolic process (GO:0006641) | 3.98297170 |
| 57 | porphyrin-containing compound biosynthetic process (GO:0006779) | 3.95660469 |
| 58 | NADPH regeneration (GO:0006740) | 3.90915493 |
| 59 | protoporphyrinogen IX biosynthetic process (GO:0006782) | 3.88438791 |
| 60 | iron ion import (GO:0097286) | 3.88015344 |
| 61 | water-soluble vitamin biosynthetic process (GO:0042364) | 3.87724643 |
| 62 | carnitine transmembrane transport (GO:1902603) | 3.85137094 |
| 63 | purine ribonucleoside bisphosphate metabolic process (GO:0034035) | 3.81886607 |
| 64 | 3-phosphoadenosine 5-phosphosulfate metabolic process (GO:0050427) | 3.81886607 |
| 65 | cilium or flagellum-dependent cell motility (GO:0001539) | 3.81487166 |
| 66 | NADH metabolic process (GO:0006734) | 3.79486440 |
| 67 | response to dietary excess (GO:0002021) | 3.75524244 |
| 68 | neuromuscular synaptic transmission (GO:0007274) | 3.72166614 |
| 69 | acylglycerol metabolic process (GO:0006639) | 3.71099873 |
| 70 | sensory perception of taste (GO:0050909) | 3.70539117 |
| 71 | positive regulation of fatty acid oxidation (GO:0046321) | 3.70306065 |
| 72 | DNA replication checkpoint (GO:0000076) | 3.69829055 |
| 73 | regulation of lipid storage (GO:0010883) | 3.69480699 |
| 74 | positive regulation of heat generation (GO:0031652) | 3.68705286 |
| 75 | tetrapyrrole biosynthetic process (GO:0033014) | 3.68044955 |
| 76 | DNA deamination (GO:0045006) | 3.66734191 |
| 77 | lens fiber cell differentiation (GO:0070306) | 3.66653794 |
| 78 | detection of light stimulus involved in visual perception (GO:0050908) | 3.65747973 |
| 79 | detection of light stimulus involved in sensory perception (GO:0050962) | 3.65747973 |
| 80 | neutral lipid metabolic process (GO:0006638) | 3.65478818 |
| 81 | G-protein coupled purinergic nucleotide receptor signaling pathway (GO:0035589) | 3.65474167 |
| 82 | regulation of hippo signaling (GO:0035330) | 3.65358336 |
| 83 | regulation of synapse structural plasticity (GO:0051823) | 3.61972086 |
| 84 | adenine nucleotide transport (GO:0051503) | 3.61807499 |
| 85 | regulation of cellular response to vascular endothelial growth factor stimulus (GO:1902547) | 3.61248233 |
| 86 | tricarboxylic acid metabolic process (GO:0072350) | 3.60738472 |
| 87 | CDP-diacylglycerol metabolic process (GO:0046341) | 3.60722594 |
| 88 | phosphatidic acid biosynthetic process (GO:0006654) | 3.58382671 |
| 89 | phosphatidic acid metabolic process (GO:0046473) | 3.58382671 |
| 90 | negative regulation of granulocyte differentiation (GO:0030853) | 3.57601836 |
| 91 | positive regulation of fatty acid beta-oxidation (GO:0032000) | 3.57400418 |
| 92 | fatty acid homeostasis (GO:0055089) | 3.56230359 |
| 93 | cellular response to lithium ion (GO:0071285) | 3.55071107 |
| 94 | regulation of macrophage derived foam cell differentiation (GO:0010743) | 3.54658414 |
| 95 | fatty acid catabolic process (GO:0009062) | 3.54127109 |
| 96 | negative regulation of lipopolysaccharide-mediated signaling pathway (GO:0031665) | 3.53234745 |
| 97 | intracellular lipid transport (GO:0032365) | 3.51741640 |
| 98 | pseudouridine synthesis (GO:0001522) | 3.51259088 |
| 99 | negative regulation of gluconeogenesis (GO:0045721) | 3.50302664 |
| 100 | amino-acid betaine transport (GO:0015838) | 3.48982604 |
| 101 | carnitine transport (GO:0015879) | 3.48982604 |
| 102 | CDP-diacylglycerol biosynthetic process (GO:0016024) | 3.47974197 |
| 103 | regulation of posttranscriptional gene silencing (GO:0060147) | 3.47920689 |
| 104 | regulation of gene silencing by miRNA (GO:0060964) | 3.47920689 |
| 105 | regulation of gene silencing by RNA (GO:0060966) | 3.47920689 |
| 106 | preassembly of GPI anchor in ER membrane (GO:0016254) | 3.45769578 |
| 107 | plasma lipoprotein particle clearance (GO:0034381) | 3.44146491 |
| 108 | adenosine receptor signaling pathway (GO:0001973) | 3.42684562 |
| 109 | kynurenine metabolic process (GO:0070189) | 3.42032796 |
| 110 | regulation of fatty acid oxidation (GO:0046320) | 3.41562109 |
| 111 | cornea development in camera-type eye (GO:0061303) | 3.41261011 |
| 112 | UV protection (GO:0009650) | 3.41074556 |
| 113 | positive regulation of synaptic transmission, dopaminergic (GO:0032226) | 3.40840158 |
| 114 | coenzyme A metabolic process (GO:0015936) | 3.39947661 |
| 115 | regulation of triglyceride biosynthetic process (GO:0010866) | 3.39276930 |
| 116 | fatty acid oxidation (GO:0019395) | 3.38757478 |
| 117 | growth hormone receptor signaling pathway (GO:0060396) | 3.38608950 |
| 118 | purinergic receptor signaling pathway (GO:0035587) | 3.38491183 |
| 119 | lipid oxidation (GO:0034440) | 3.34815601 |
| 120 | retina vasculature morphogenesis in camera-type eye (GO:0061299) | 3.32082313 |
| 121 | sex determination (GO:0007530) | 3.30540793 |
| 122 | negative regulation of tumor necrosis factor-mediated signaling pathway (GO:0010804) | 3.30131476 |
| 123 | ovulation from ovarian follicle (GO:0001542) | 3.29290450 |
| 124 | positive regulation of defense response to virus by host (GO:0002230) | 3.28181208 |
| 125 | positive regulation of macrophage cytokine production (GO:0060907) | 3.27985817 |
| 126 | response to lipoprotein particle (GO:0055094) | 3.26851518 |
| 127 | reciprocal DNA recombination (GO:0035825) | 3.26679772 |
| 128 | reciprocal meiotic recombination (GO:0007131) | 3.26679772 |
| 129 | protein import into peroxisome matrix (GO:0016558) | 3.26376919 |
| 130 | purine ribonucleotide transport (GO:0015868) | 3.22838842 |
| 131 | negative regulation of macrophage differentiation (GO:0045650) | 3.22332573 |
| 132 | negative regulation of DNA biosynthetic process (GO:2000279) | 3.22330734 |
| 133 | creatine metabolic process (GO:0006600) | 3.21243744 |
| 134 | indolalkylamine metabolic process (GO:0006586) | 3.20898606 |
| 135 | positive regulation of cholesterol efflux (GO:0010875) | 3.20873931 |
| 136 | fucose catabolic process (GO:0019317) | 3.20695772 |
| 137 | L-fucose metabolic process (GO:0042354) | 3.20695772 |
| 138 | L-fucose catabolic process (GO:0042355) | 3.20695772 |
| 139 | regulation of acetyl-CoA biosynthetic process from pyruvate (GO:0010510) | 3.20590588 |
| 140 | respiratory chain complex IV assembly (GO:0008535) | 3.17824766 |
| 141 | regulation of protein kinase A signaling (GO:0010738) | 3.17221299 |
| 142 | axoneme assembly (GO:0035082) | 3.17002049 |
| 143 | protein heterotrimerization (GO:0070208) | 3.15468333 |
| 144 | epithelial cilium movement involved in determination of left/right asymmetry (GO:0060287) | 3.13771114 |
| 145 | mitotic cell cycle arrest (GO:0071850) | 3.11988780 |
| 146 | heme metabolic process (GO:0042168) | 3.11588366 |
| 147 | base-excision repair, AP site formation (GO:0006285) | 3.08876347 |
| 148 | sialylation (GO:0097503) | 3.08583847 |
| 149 | negative regulation of protein autophosphorylation (GO:0031953) | 3.08030022 |
| 150 | regulation of action potential (GO:0098900) | 3.07926279 |
| 151 | regulation of fatty acid beta-oxidation (GO:0031998) | 3.04995594 |
| 152 | positive regulation of triglyceride metabolic process (GO:0090208) | 3.01900397 |
| 153 | regulation of triglyceride metabolic process (GO:0090207) | 2.99901500 |
| 154 | cytochrome complex assembly (GO:0017004) | 2.99108328 |
| 155 | tryptophan catabolic process (GO:0006569) | 2.98962709 |
| 156 | indole-containing compound catabolic process (GO:0042436) | 2.98962709 |
| 157 | indolalkylamine catabolic process (GO:0046218) | 2.98962709 |
| 158 | peptidyl-histidine modification (GO:0018202) | 2.96981014 |
| 159 | long-chain fatty acid transport (GO:0015909) | 2.95399871 |
| 160 | tricarboxylic acid cycle (GO:0006099) | 2.94111286 |
| 161 | pantothenate metabolic process (GO:0015939) | 2.93857806 |
| 162 | positive regulation of sterol transport (GO:0032373) | 2.93040038 |
| 163 | positive regulation of cholesterol transport (GO:0032376) | 2.93040038 |
| 164 | cellular response to zinc ion (GO:0071294) | 2.92203513 |
| 165 | phosphatidylglycerol biosynthetic process (GO:0006655) | 2.91259982 |
| 166 | negative regulation of metanephros development (GO:0072217) | 2.89837193 |
| 167 | nucleoside transport (GO:0015858) | 2.89566511 |
| 168 | mannosylation (GO:0097502) | 2.89047831 |
| 169 | glucose catabolic process (GO:0006007) | 2.89038623 |
| 170 | dolichol-linked oligosaccharide biosynthetic process (GO:0006488) | 2.88966015 |
| 171 | synaptic transmission, cholinergic (GO:0007271) | 2.87933292 |
| 172 | porphyrin-containing compound metabolic process (GO:0006778) | 2.87448276 |
| 173 | cellular response to growth hormone stimulus (GO:0071378) | 2.87313520 |
| 174 | RNA modification (GO:0009451) | 2.86482965 |
| 175 | motile cilium assembly (GO:0044458) | 2.85429627 |
| 176 | tryptophan metabolic process (GO:0006568) | 2.83558184 |
| 177 | gonadal mesoderm development (GO:0007506) | 2.80348063 |
| 178 | piRNA metabolic process (GO:0034587) | 2.78675238 |
| 179 | iron coordination entity transport (GO:1901678) | 2.77532904 |
| 180 | cellular response to exogenous dsRNA (GO:0071360) | 2.76953034 |
| 181 | L-methionine biosynthetic process from methylthioadenosine (GO:0019509) | 2.74462706 |
| 182 | negative regulation of reactive oxygen species metabolic process (GO:2000378) | 2.71993359 |
| 183 | regulation of hydrogen peroxide metabolic process (GO:0010310) | 2.71844853 |
| 184 | NAD biosynthetic process (GO:0009435) | 2.71505819 |
| 185 | photoreceptor cell development (GO:0042461) | 2.68621565 |
| 186 | neuronal action potential (GO:0019228) | 2.67817323 |
| 187 | DNA damage response, signal transduction by p53 class mediator resulting in transcription of p21 cla | 2.67071633 |
| 188 | cellular ketone body metabolic process (GO:0046950) | 2.63109421 |
| 189 | positive regulation of triglyceride biosynthetic process (GO:0010867) | 2.63070509 |
| 190 | eye photoreceptor cell development (GO:0042462) | 2.61692797 |
| 191 | histone phosphorylation (GO:0016572) | 2.60051239 |
| 192 | purine nucleotide transport (GO:0015865) | 2.59325541 |
| 193 | metallo-sulfur cluster assembly (GO:0031163) | 2.56100165 |
| 194 | iron-sulfur cluster assembly (GO:0016226) | 2.56100165 |
| 195 | tRNA processing (GO:0008033) | 2.54016889 |
| 196 | transepithelial transport (GO:0070633) | 2.52006041 |
| 197 | cardiolipin metabolic process (GO:0032048) | 2.50927246 |
| 198 | sympathetic nervous system development (GO:0048485) | 2.49634733 |
| 199 | fucosylation (GO:0036065) | 2.49505513 |
| 200 | melanin biosynthetic process (GO:0042438) | 2.49195826 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | TAF7L_23326641_ChIP-Seq_C3H10T1-2_Mouse | 5.16953665 |
| 2 | STAT6_21828071_ChIP-Seq_BEAS2B_Human | 4.16147649 |
| 3 | CLOCK_20551151_ChIP-Seq_293T_Human | 3.46750375 |
| 4 | CTNNB1_20615089_ChIP-ChIP_FETAL_BRAIN_Human | 3.06533846 |
| 5 | TP63_17297297_ChIP-ChIP_HaCaT_Human | 2.95707331 |
| 6 | ZNF263_19887448_ChIP-Seq_K562_Human | 2.79915119 |
| 7 | EKLF_21900194_ChIP-Seq_ERYTHROCYTE_Mouse | 2.77327121 |
| 8 | GATA1_22025678_ChIP-Seq_K562_Human | 2.55108166 |
| 9 | FOXP1_22492998_ChIP-Seq_STRATIUM_Mouse | 2.53207508 |
| 10 | EZH2_23942234_ChIP-Seq_MYOBLASTS_AND_MYOTUBES_Mouse | 2.48457847 |
| 11 | E2F1_20622854_ChIP-Seq_HELA_Human | 2.47573118 |
| 12 | CTCF_27219007_Chip-Seq_Bcells_Human | 2.43264614 |
| 13 | BCL6_27268052_Chip-Seq_Bcells_Human | 2.39915826 |
| 14 | PHF8_20622854_ChIP-Seq_HELA_Human | 2.31096014 |
| 15 | TBP_23326641_ChIP-Seq_C3H10T1-2_Mouse | 2.19889653 |
| 16 | ERA_21632823_ChIP-Seq_H3396_Human | 2.12798459 |
| 17 | NOTCH1_21737748_ChIP-Seq_TLL_Human | 2.05598467 |
| 18 | NUCKS1_24931609_ChIP-Seq_HEPATOCYTES_Mouse | 2.05530834 |
| 19 | IKZF1_21737484_ChIP-ChIP_HCT116_Human | 2.01920401 |
| 20 | * MYCN_27167114_Chip-Seq_NEUROBLASTOMA_Human | 2.00524008 |
| 21 | PPARG_19300518_ChIP-PET_3T3-L1_Mouse | 11.1540602 |
| 22 | NR1H3_23393188_ChIP-Seq_ATHEROSCLEROTIC-FOAM_Human | 1.96442597 |
| 23 | EBNA2_21746931_ChIP-Seq_IB4-LCL_Human | 1.95653717 |
| 24 | ERG_21242973_ChIP-ChIP_JURKAT_Human | 1.94506683 |
| 25 | E2F7_22180533_ChIP-Seq_HELA_Human | 1.90307255 |
| 26 | * RARB_24833708_ChIP-Seq_LIVER_Mouse | 1.87311620 |
| 27 | RBPJ_21746931_ChIP-Seq_IB4-LCL_Human | 1.82959686 |
| 28 | FOXP1_21924763_ChIP-Seq_HESCs_Human | 1.80397940 |
| 29 | TET1_21451524_ChIP-Seq_MESCs_Mouse | 1.79889080 |
| 30 | SMC4_20622854_ChIP-Seq_HELA_Human | 1.79693571 |
| 31 | STAT5_23275557_ChIP-Seq_MAMMARY-EPITHELIUM_Mouse | 1.74715432 |
| 32 | VDR_21846776_ChIP-Seq_THP-1_Human | 1.72250614 |
| 33 | CTCF_20526341_ChIP-Seq_ESCs_Human | 1.70007319 |
| 34 | IRF8_22096565_ChIP-ChIP_GC-B_Human | 1.68287769 |
| 35 | ELK3_25401928_ChIP-Seq_HUVEC_Human | 1.67179388 |
| 36 | RARA_24833708_ChIP-Seq_LIVER_Mouse | 1.66477544 |
| 37 | RXRA_24833708_ChIP-Seq_LIVER_Mouse | 1.63186314 |
| 38 | TCF21_23034159_ChIP-ChIP_E13_GONADS_Rat | 1.62555052 |
| 39 | P53_21459846_ChIP-Seq_SAOS-2_Human | 1.62230442 |
| 40 | OCT4_20526341_ChIP-Seq_ESCs_Human | 1.62050993 |
| 41 | ESR1_17901129_ChIP-ChIP_LIVER_Mouse | 1.57964834 |
| 42 | RARG_19884340_ChIP-ChIP_MEFs_Mouse | 1.57921389 |
| 43 | TAF2_19829295_ChIP-Seq_ESCs_Human | 1.57822699 |
| 44 | CTCF_27219007_Chip-Seq_ERYTHROID_Human | 1.57342722 |
| 45 | CREB1_15753290_ChIP-ChIP_HEK293T_Human | 1.57015117 |
| 46 | THRA_23701648_ChIP-Seq_CEREBELLUM_Mouse | 1.55949185 |
| 47 | RXR_22158963_ChIP-Seq_LIVER_Mouse | 1.55684625 |
| 48 | STAT3_22323479_ChIP-Seq_MACROPHAGE_Mouse | 1.54321673 |
| 49 | IRF8_21731497_ChIP-ChIP_J774_Mouse | 1.54105695 |
| 50 | PPARA_22158963_ChIP-Seq_LIVER_Mouse | 1.53504887 |
| 51 | * P300_27268052_Chip-Seq_Bcells_Human | 1.53170659 |
| 52 | SA1_27219007_Chip-Seq_Bcells_Human | 1.52950224 |
| 53 | DROSHA_22980978_ChIP-Seq_HELA_Human | 1.52501902 |
| 54 | EWS-ERG_20517297_ChIP-Seq_CADO-ES1_Human | 1.47482136 |
| 55 | STAT3_1855785_ChIP-Seq_MESCs_Mouse | 1.47373307 |
| 56 | TFAP2A_17053090_ChIP-ChIP_MCF-7_Human | 1.45907380 |
| 57 | CEBPB_24764292_ChIP-Seq_MC3T3_Mouse | 1.44560097 |
| 58 | CEBPB_23403033_ChIP-Seq_LIVER_Mouse | 1.44384823 |
| 59 | NANOG_20526341_ChIP-Seq_ESCs_Human | 1.42918800 |
| 60 | SA1_27219007_Chip-Seq_ERYTHROID_Human | 1.42491520 |
| 61 | CTCF_21964334_Chip-Seq_Bcells_Human | 1.42182944 |
| 62 | ZNF274_21170338_ChIP-Seq_K562_Hela | 1.40666575 |
| 63 | CTCF_21964334_ChIP-Seq_BJAB-B_Human | 1.40357822 |
| 64 | * SRY_25088423_ChIP-ChIP_EMBRYONIC_GONADS_Mouse | 1.39842899 |
| 65 | E4F1_26484288_ChIP-Seq_MOUSE_EMBRYONIC_FIBROBLAST_Mouse | 1.39793378 |
| 66 | SPI1_26923725_Chip-Seq_MACROPHAGESS_Mouse | 1.39733640 |
| 67 | PPARG_20887899_ChIP-Seq_3T3-L1_Mouse | 1.35764259 |
| 68 | KLF4_18555785_ChIP-Seq_MESCs_Mouse | 1.35283101 |
| 69 | SOX9_25088423_ChIP-ChIP_EMBRYONIC_GONADS_Mouse | 1.35127640 |
| 70 | RAC3_21632823_ChIP-Seq_H3396_Human | 1.33266709 |
| 71 | OCT4_19829295_ChIP-Seq_ESCs_Human | 1.32729506 |
| 72 | SRY_22984422_ChIP-ChIP_TESTIS_Rat | 1.32504184 |
| 73 | HOXC9_25013753_ChIP-Seq_NEUROBLASTOMA_BE2-C_Human | 1.31439593 |
| 74 | EZH2_27294783_Chip-Seq_ESCs_Mouse | 1.30959115 |
| 75 | SREBP1_19666523_ChIP-Seq_LIVER_Mouse | 1.30711721 |
| 76 | PRDM16_22522345_ChIP-ChIP_PALATE_MESENCHYMAL_Mouse | 1.29888870 |
| 77 | KLF6_26769127_Chip-Seq_PDAC-Cell_line_Human | 1.29578178 |
| 78 | CEBPB_21427703_ChIP-Seq_3T3-L1_Mouse | 1.28986465 |
| 79 | * NEUROD2_26341353_ChIP-Seq_CORTEX_Mouse | 1.28980838 |
| 80 | TP53_22127205_ChIP-Seq_IMR90_Human | 1.28097162 |
| 81 | RUNX1_22897851_ChIP-Seq_JUKARTE6-1_Human | 1.26879754 |
| 82 | * TP63_22573176_ChIP-Seq_HFKS_Human | 1.26467975 |
| 83 | ESRRB_18555785_ChIP-Seq_MESCs_Mouse | 1.26403664 |
| 84 | CREB1_26743006_Chip-Seq_LNCaP-abl_Human | 1.25632746 |
| 85 | * FLI1_26923725_Chip-Seq_HEMOGENIC-ENDOTHELIUM_Mouse | 1.25179859 |
| 86 | PPARD_23208498_ChIP-Seq_MDA-MB-231_Human | 1.24984842 |
| 87 | ATF3_27146783_Chip-Seq_COLON_Human | 1.23542361 |
| 88 | * TCF21_26020271_ChIP-Seq_SMOOTH_MUSCLE_Human | 1.23412544 |
| 89 | ETS1_20019798_ChIP-Seq_JURKAT_Human | 1.23380155 |
| 90 | JARID1A_20064375_ChIP-Seq_MESCs_Mouse | 1.23276197 |
| 91 | RCOR2_21632747_ChIP-Seq_MESCs_Mouse | 1.22648178 |
| 92 | TDRD3_21172665_ChIP-Seq_MCF-7_Human | 1.22586998 |
| 93 | TFEB_21752829_ChIP-Seq_HELA_Human | 1.22513432 |
| 94 | CREB1_26743006_Chip-Seq_LNCaP_Human | 1.21319246 |
| 95 | * TAL1_20566737_ChIP-Seq_PRIMARY_FETAL_LIVER_ERYTHROID_Mouse | 1.20525916 |
| 96 | TP53_22573176_ChIP-Seq_HFKS_Human | 1.20378107 |
| 97 | ETS1_21867929_ChIP-Seq_TH2_Mouse | 1.20339579 |
| 98 | RACK7_27058665_Chip-Seq_MCF-7_Human | 1.20193256 |
| 99 | * GATA1_19941826_ChIP-Seq_K562_Human | 1.19800693 |
| 100 | MYC_19829295_ChIP-Seq_ESCs_Human | 1.18390794 |
| 101 | ZNF652_21678463_ChIP-ChIP_ZR75-1_Human | 1.16171659 |
| 102 | MAF_26560356_Chip-Seq_TH2_Human | 1.16042233 |
| 103 | SRF_21415370_ChIP-Seq_HL-1_Mouse | 1.12460915 |
| 104 | KDM2B_26808549_Chip-Seq_DND41_Human | 1.11344841 |
| 105 | * DACH1_20351289_ChIP-Seq_MDA-MB-231_Human | 1.11261519 |
| 106 | LXR_22292898_ChIP-Seq_THP-1_Human | 1.10866394 |
| 107 | LXR_22158963_ChIP-Seq_LIVER_Mouse | 1.10827505 |
| 108 | GATA3_21867929_ChIP-Seq_CD8_Mouse | 1.10393936 |
| 109 | DCP1A_22483619_ChIP-Seq_HELA_Human | 1.10387053 |
| 110 | MYCN_21190229_ChIP-Seq_SHEP-21N_Human | 1.10263132 |
| 111 | P300_27058665_Chip-Seq_ZR-75-30cells_Human | 1.10186544 |
| 112 | * EBNA1_20929547_Chip-Seq_RAJI-cells_Human | 1.10128540 |
| 113 | * E2F4_21247883_ChIP-Seq_LYMPHOBLASTOID_Human | 1.08743173 |
| 114 | * GATA1_19941827_ChIP-Seq_MEL_Mouse | 1.07850293 |
| 115 | PPARG_20176806_ChIP-Seq_3T3-L1_Mouse | 1.07718328 |
| 116 | MYB_21317192_ChIP-Seq_ERMYB_Mouse | 1.06477331 |
| 117 | TRIM28_21343339_ChIP-Seq_HEK293_Human | 1.06465537 |
| 118 | BCL3_23251550_ChIP-Seq_MUSCLE_Mouse | 1.05522685 |
| 119 | * GATA3_21878914_ChIP-Seq_MCF-7_Human | 1.04784705 |
| 120 | EGR1_20690147_ChIP-Seq_ERYTHROLEUKEMIA_Human | 1.04440810 |
| 121 | MYC_18555785_ChIP-Seq_MESCs_Mouse | 1.04366349 |
| 122 | KLF4_18358816_ChIP-ChIP_MESCs_Mouse | 1.04035129 |
| 123 | NR0B1_18358816_ChIP-ChIP_MESCs_Mouse | 1.03832906 |
| 124 | * GATA1_22383799_ChIP-Seq_G1ME_Mouse | 1.03796395 |
| 125 | VDR_22108803_ChIP-Seq_LS180_Human | 1.03180838 |
| 126 | * P63_20808887_ChIP-Seq_KERATINOCYTES_Human | 1.02666101 |
| 127 | PU.1_20513432_ChIP-Seq_Bcells_Mouse | 1.02446859 |
| 128 | DMRT1_21621532_ChIP-ChIP_FETAL_Ovary | 1.02404455 |
| 129 | * TP53_23651856_ChIP-Seq_MEFs_Mouse | 1.02141994 |
| 130 | KDM2B_26808549_Chip-Seq_SIL-ALL_Human | 1.01839205 |
| 131 | KLF1_20508144_ChIP-Seq_FETAL-LIVER-ERYTHROID_Mouse | 1.01407546 |
| 132 | MYC_18358816_ChIP-ChIP_MESCs_Mouse | 1.00904859 |
| 133 | * ATF3_23680149_ChIP-Seq_GBM1-GSC_Human | 1.00790195 |
| 134 | SMC3_22415368_ChIP-Seq_MEFs_Mouse | 1.00592853 |
| 135 | * MAF_26560356_Chip-Seq_TH1_Human | 1.00414878 |
| 136 | SOX2_21211035_ChIP-Seq_LN229_Human | 0.99610706 |
| 137 | UTX_26944678_Chip-Seq_JUKART_Human | 0.99545931 |
| 138 | E2F1_18555785_ChIP-Seq_MESCs_Mouse | 0.99440402 |
| 139 | GABP_19822575_ChIP-Seq_HepG2_Human | 0.99405173 |
| 140 | KDM2B_26808549_Chip-Seq_HPB-ALL_Human | 0.99036455 |
| 141 | P68_20966046_ChIP-Seq_HELA_Human | 0.97263254 |
| 142 | KDM2B_26808549_Chip-Seq_SUP-B15_Human | 0.96133222 |
| 143 | FOXO1_23066095_ChIP-Seq_LIVER_Mouse | 0.95401326 |
| 144 | SMARCA4_20176728_ChIP-ChIP_TSCs_Mouse | 0.95326140 |
| 145 | HIF1A_21447827_ChIP-Seq_MCF-7_Human | 0.94456126 |
| 146 | NELFA_20434984_ChIP-Seq_ESCs_Mouse | 0.93968180 |
| 147 | FOXO3_23340844_ChIP-Seq_DLD1_Human | 0.93798647 |
| 148 | KLF4_26769127_Chip-Seq_PDAC-Cell_line_Human | 0.93389095 |
| 149 | CEBPB_20176806_ChIP-Seq_MACROPHAGES_Mouse | 0.90418516 |
| 150 | XRN2_22483619_ChIP-Seq_HELA_Human | 0.90332603 |
| 151 | TCFAP2C_20176728_ChIP-ChIP_TROPHOBLAST_STEM_CELLS_Mouse | 0.89928741 |
| 152 | RUNX2_24764292_ChIP-Seq_MC3T3_Mouse | 0.89733205 |
| 153 | BCOR_27268052_Chip-Seq_Bcells_Human | 0.89660369 |
| 154 | NCOR_22465074_ChIP-Seq_MACROPHAGES_Mouse | 0.89023674 |
| 155 | BRD4_27068464_Chip-Seq_AML-cells_Mouse | 0.88675927 |
| 156 | ELF1_20517297_ChIP-Seq_JURKAT_Human | 0.88616765 |
| 157 | MYC_22102868_ChIP-Seq_BL_Human | 0.86724323 |
| 158 | * TBX5_21415370_ChIP-Seq_HL-1_Mouse | 0.86666410 |
| 159 | KDM5A_27292631_Chip-Seq_BREAST_Human | 0.85812690 |
| 160 | * P63_26484246_Chip-Seq_KERATINOCYTES_Human | 0.85792745 |
| 161 | PPAR_26484153_Chip-Seq_NCI-H1993_Human | 0.85274602 |
| 162 | * NCOR1_26117541_ChIP-Seq_K562_Human | 0.84991122 |
| 163 | RELA_24523406_ChIP-Seq_FIBROSARCOMA_Human | 0.84948162 |
| 164 | VDR_24763502_ChIP-Seq_THP-1_Human | 0.84563550 |
| 165 | YY1_22570637_ChIP-Seq_MALME-3M_Human | 0.83386374 |
| 166 | E2A_27217539_Chip-Seq_RAMOS-Cell_line_Human | 0.83364996 |
| 167 | CEBPA_23403033_ChIP-Seq_LIVER_Mouse | 0.83342768 |
| 168 | CCND1_20090754_ChIP-ChIP_RETINA_Mouse | 0.83120095 |
| 169 | NANOG_18555785_ChIP-Seq_MESCs_Mouse | 0.82933635 |
| 170 | SMRT_22465074_ChIP-Seq_MACROPHAGES_Mouse | 0.81868132 |
| 171 | UBF1/2_26484160_Chip-Seq_HMEC-DERIVED_Human | 0.81787679 |
| 172 | NKX2-5_21415370_ChIP-Seq_HL-1_Mouse | 0.81565816 |
| 173 | * SMAD2/3_21741376_ChIP-Seq_ESCs_Human | 0.81274432 |
| 174 | ELF3_26769127_Chip-Seq_PDAC-Cell_line_Human | 0.79661328 |
| 175 | TBX20_22328084_ChIP-Seq_HEART_Mouse | 0.79374031 |
| 176 | TBX20_22080862_ChIP-Seq_HEART_Mouse | 0.79374031 |
| 177 | GABP_17652178_ChIP-ChIP_JURKAT_Human | 0.78268811 |
| 178 | CTCF_26484167_Chip-Seq_Bcells_Mouse | 0.78265082 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | MP0005670_abnormal_white_adipose | 6.46263124 |
| 2 | MP0001986_abnormal_taste_sensitivity | 5.89469777 |
| 3 | MP0003136_yellow_coat_color | 5.24693666 |
| 4 | MP0005171_absent_coat_pigmentation | 5.13597710 |
| 5 | MP0005423_abnormal_somatic_nervous | 5.11528057 |
| 6 | MP0005174_abnormal_tail_pigmentation | 4.94373895 |
| 7 | MP0004185_abnormal_adipocyte_glucose | 4.83531418 |
| 8 | MP0005666_abnormal_adipose_tissue | 4.70590980 |
| 9 | MP0004130_abnormal_muscle_cell | 4.09254413 |
| 10 | MP0001968_abnormal_touch/_nociception | 3.84878784 |
| 11 | MP0004147_increased_porphyrin_level | 3.49538712 |
| 12 | MP0005375_adipose_tissue_phenotype | 3.44200026 |
| 13 | MP0001188_hyperpigmentation | 3.38842215 |
| 14 | MP0008438_abnormal_cutaneous_collagen | 3.29469897 |
| 15 | MP0003656_abnormal_erythrocyte_physiolo | 3.22667692 |
| 16 | MP0002638_abnormal_pupillary_reflex | 2.80176977 |
| 17 | MP0002971_abnormal_brown_adipose | 2.80002365 |
| 18 | MP0002736_abnormal_nociception_after | 2.63025155 |
| 19 | MP0002837_dystrophic_cardiac_calcinosis | 2.47796744 |
| 20 | MP0008875_abnormal_xenobiotic_pharmacok | 2.45249575 |
| 21 | MP0009115_abnormal_fat_cell | 2.40700711 |
| 22 | MP0000003_abnormal_adipose_tissue | 2.34762596 |
| 23 | MP0004043_abnormal_pH_regulation | 2.25542764 |
| 24 | MP0005409_darkened_coat_color | 2.19041544 |
| 25 | MP0002254_reproductive_system_inflammat | 2.08079302 |
| 26 | MP0005334_abnormal_fat_pad | 2.07814570 |
| 27 | MP0004381_abnormal_hair_follicle | 2.07676410 |
| 28 | MP0002970_abnormal_white_adipose | 2.03612251 |
| 29 | MP0001502_abnormal_circadian_rhythm | 2.02399923 |
| 30 | MP0000013_abnormal_adipose_tissue | 2.01062577 |
| 31 | MP0002876_abnormal_thyroid_physiology | 1.95967808 |
| 32 | MP0005551_abnormal_eye_electrophysiolog | 1.92528269 |
| 33 | MP0003705_abnormal_hypodermis_morpholog | 1.91610001 |
| 34 | MP0001881_abnormal_mammary_gland | 1.77129697 |
| 35 | MP0003191_abnormal_cellular_cholesterol | 1.74787615 |
| 36 | MP0005275_abnormal_skin_tensile | 1.73973598 |
| 37 | MP0003959_abnormal_lean_body | 1.72604734 |
| 38 | MP0003186_abnormal_redox_activity | 1.71165332 |
| 39 | MP0000015_abnormal_ear_pigmentation | 1.71155383 |
| 40 | MP0010329_abnormal_lipoprotein_level | 1.68010986 |
| 41 | MP0000538_abnormal_urinary_bladder | 1.65950600 |
| 42 | MP0001661_extended_life_span | 1.63940971 |
| 43 | MP0002118_abnormal_lipid_homeostasis | 1.61182864 |
| 44 | MP0003646_muscle_fatigue | 1.56098471 |
| 45 | MP0005535_abnormal_body_temperature | 1.53789021 |
| 46 | MP0003724_increased_susceptibility_to | 1.53657465 |
| 47 | MP0000750_abnormal_muscle_regeneration | 1.52636250 |
| 48 | MP0002735_abnormal_chemical_nociception | 1.52225233 |
| 49 | MP0005058_abnormal_lysosome_morphology | 1.51794759 |
| 50 | MP0008872_abnormal_physiological_respon | 1.49568092 |
| 51 | MP0002166_altered_tumor_susceptibility | 1.48607485 |
| 52 | MP0009840_abnormal_foam_cell | 1.43897248 |
| 53 | MP0003828_pulmonary_edema | 1.43444415 |
| 54 | MP0002332_abnormal_exercise_endurance | 1.43283220 |
| 55 | MP0004145_abnormal_muscle_electrophysio | 1.40398247 |
| 56 | MP0000609_abnormal_liver_physiology | 1.35745124 |
| 57 | MP0008775_abnormal_heart_ventricle | 1.35244059 |
| 58 | MP0002006_tumorigenesis | 1.35240130 |
| 59 | MP0005452_abnormal_adipose_tissue | 1.30010731 |
| 60 | MP0010386_abnormal_urinary_bladder | 1.27461395 |
| 61 | MP0001970_abnormal_pain_threshold | 1.26935252 |
| 62 | MP0004272_abnormal_basement_membrane | 1.26426060 |
| 63 | MP0003137_abnormal_impulse_conducting | 1.25809912 |
| 64 | MP0005448_abnormal_energy_balance | 1.25419346 |
| 65 | MP0001765_abnormal_ion_homeostasis | 1.25100135 |
| 66 | MP0004087_abnormal_muscle_fiber | 1.24706967 |
| 67 | MP0005332_abnormal_amino_acid | 1.24519106 |
| 68 | MP0003221_abnormal_cardiomyocyte_apopto | 1.24442540 |
| 69 | MP0006276_abnormal_autonomic_nervous | 1.23460041 |
| 70 | MP0006036_abnormal_mitochondrial_physio | 1.21098171 |
| 71 | MP0002269_muscular_atrophy | 1.19345559 |
| 72 | MP0000759_abnormal_skeletal_muscle | 1.18950433 |
| 73 | MP0005646_abnormal_pituitary_gland | 1.18245329 |
| 74 | MP0000751_myopathy | 1.16372353 |
| 75 | MP0001664_abnormal_digestion | 1.13659559 |
| 76 | MP0000685_abnormal_immune_system | 1.13100575 |
| 77 | MP0000749_muscle_degeneration | 1.12001390 |
| 78 | MP0001873_stomach_inflammation | 1.10841336 |
| 79 | MP0003693_abnormal_embryo_hatching | 1.10429027 |
| 80 | MP0005397_hematopoietic_system_phenotyp | 1.10348882 |
| 81 | MP0001545_abnormal_hematopoietic_system | 1.10348882 |
| 82 | MP0002160_abnormal_reproductive_system | 1.08624204 |
| 83 | MP0002009_preneoplasia | 1.08057281 |
| 84 | MP0003566_abnormal_cell_adhesion | 1.05748963 |
| 85 | MP0004133_heterotaxia | 1.05083065 |
| 86 | MP0000343_altered_response_to | 1.04898444 |
| 87 | MP0009745_abnormal_behavioral_response | 1.04841860 |
| 88 | MP0000747_muscle_weakness | 1.02017247 |
| 89 | MP0001348_abnormal_lacrimal_gland | 1.01479294 |
| 90 | MP0005385_cardiovascular_system_phenoty | 1.01420129 |
| 91 | MP0001544_abnormal_cardiovascular_syste | 1.01420129 |
| 92 | MP0005410_abnormal_fertilization | 1.00593447 |
| 93 | MP0003690_abnormal_glial_cell | 1.00551926 |
| 94 | MP0005330_cardiomyopathy | 1.00498354 |
| 95 | MP0005076_abnormal_cell_differentiation | 0.99969558 |
| 96 | MP0002078_abnormal_glucose_homeostasis | 0.98812274 |
| 97 | MP0001905_abnormal_dopamine_level | 0.98539034 |
| 98 | MP0008260_abnormal_autophagy | 0.98203332 |
| 99 | MP0003195_calcinosis | 0.97873341 |
| 100 | MP0005083_abnormal_biliary_tract | 0.97695936 |
| 101 | MP0003111_abnormal_nucleus_morphology | 0.96552064 |
| 102 | MP0002272_abnormal_nervous_system | 0.92832860 |
| 103 | MP0006138_congestive_heart_failure | 0.91015151 |
| 104 | MP0002106_abnormal_muscle_physiology | 0.91004721 |
| 105 | MP0000733_abnormal_muscle_development | 0.89480133 |
| 106 | MP0005584_abnormal_enzyme/coenzyme_acti | 0.89371152 |
| 107 | MP0004142_abnormal_muscle_tone | 0.89288103 |
| 108 | MP0005379_endocrine/exocrine_gland_phen | 0.88408193 |
| 109 | MP0000604_amyloidosis | 0.87933826 |
| 110 | MP0004215_abnormal_myocardial_fiber | 0.85968859 |
| 111 | MP0005451_abnormal_body_composition | 0.85275258 |
| 112 | MP0003436_decreased_susceptibility_to | 0.83064613 |
| 113 | MP0002796_impaired_skin_barrier | 0.81327857 |
| 114 | MP0009046_muscle_twitch | 0.81013229 |
| 115 | MP0005084_abnormal_gallbladder_morpholo | 0.78976703 |
| 116 | MP0000427_abnormal_hair_cycle | 0.77586084 |
| 117 | MP0005620_abnormal_muscle_contractility | 0.76054275 |
| 118 | MP0002933_joint_inflammation | 0.75869599 |
| 119 | MP0003948_abnormal_gas_homeostasis | 0.74912870 |
| 120 | MP0005389_reproductive_system_phenotype | 0.74824979 |
| 121 | MP0005253_abnormal_eye_physiology | 0.74819217 |
| 122 | MP0005319_abnormal_enzyme/_coenzyme | 0.73948282 |
| 123 | MP0001727_abnormal_embryo_implantation | 0.72444147 |
| 124 | MP0001756_abnormal_urination | 0.72105079 |
| 125 | MP0003635_abnormal_synaptic_transmissio | 0.71396239 |
| 126 | MP0001919_abnormal_reproductive_system | 0.71058220 |
| 127 | MP0002572_abnormal_emotion/affect_behav | 0.70580225 |
| 128 | MP0000627_abnormal_mammary_gland | 0.70493750 |
| 129 | MP0002063_abnormal_learning/memory/cond | 0.70342945 |
| 130 | MP0005645_abnormal_hypothalamus_physiol | 0.69560516 |
| 131 | MP0000230_abnormal_systemic_arterial | 0.69400284 |
| 132 | MP0003448_altered_tumor_morphology | 0.69289675 |
| 133 | MP0002064_seizures | 0.68510523 |
| 134 | MP0002060_abnormal_skin_morphology | 0.67409278 |
| 135 | MP0000470_abnormal_stomach_morphology | 0.67148891 |
| 136 | MP0005310_abnormal_salivary_gland | 0.66776630 |
| 137 | MP0002295_abnormal_pulmonary_circulatio | 0.65867209 |
| 138 | MP0005167_abnormal_blood-brain_barrier | 0.64516220 |
| 139 | MP0000858_altered_metastatic_potential | 0.63852808 |
| 140 | MP0004510_myositis | 0.63841385 |
| 141 | MP0009643_abnormal_urine_homeostasis | 0.63624325 |
| 142 | MP0005386_behavior/neurological_phenoty | 0.63173408 |
| 143 | MP0004924_abnormal_behavior | 0.63173408 |
| 144 | MP0008961_abnormal_basal_metabolism | 0.62163474 |
| 145 | MP0003045_fibrosis | 0.62111852 |
| 146 | MP0002067_abnormal_sensory_capabilities | 0.61982498 |
| 147 | MP0001835_abnormal_antigen_presentation | 0.61418118 |
| 148 | MP0005365_abnormal_bile_salt | 0.61391508 |
| 149 | MP0010630_abnormal_cardiac_muscle | 0.61320282 |
| 150 | MP0002733_abnormal_thermal_nociception | 0.61267022 |
| 151 | MP0003879_abnormal_hair_cell | 0.60852207 |
| 152 | MP0005377_hearing/vestibular/ear_phenot | 0.59954005 |
| 153 | MP0003878_abnormal_ear_physiology | 0.59954005 |
| 154 | MP0001533_abnormal_skeleton_physiology | 0.59506784 |
| 155 | MP0002972_abnormal_cardiac_muscle | 0.59015299 |
| 156 | MP0002163_abnormal_gland_morphology | 0.58926012 |
| 157 | MP0010307_abnormal_tumor_latency | 0.58441667 |
| 158 | MP0000598_abnormal_liver_morphology | 0.57856747 |
| 159 | MP0004019_abnormal_vitamin_homeostasis | 0.57725665 |
| 160 | MP0005369_muscle_phenotype | 0.57329696 |
| 161 | MP0005220_abnormal_exocrine_pancreas | 0.57203676 |
| 162 | MP0003698_abnormal_male_reproductive | 0.56544857 |
| 163 | MP0003329_amyloid_beta_deposits | 0.56344660 |
| 164 | MP0002210_abnormal_sex_determination | 0.55563530 |
| 165 | MP0009333_abnormal_splenocyte_physiolog | 0.55037057 |
| 166 | MP0001853_heart_inflammation | 0.55011203 |
| 167 | MP0002928_abnormal_bile_duct | 0.54590784 |
| 168 | MP0005501_abnormal_skin_physiology | 0.53618094 |
| 169 | MP0001944_abnormal_pancreas_morphology | 0.53379561 |
| 170 | MP0005164_abnormal_response_to | 0.52962092 |
| 171 | MP0006072_abnormal_retinal_apoptosis | 0.51479686 |
| 172 | MP0003806_abnormal_nucleotide_metabolis | 0.50801654 |
| 173 | MP0001486_abnormal_startle_reflex | 0.50020448 |
| 174 | MP0002075_abnormal_coat/hair_pigmentati | 0.49738662 |
| 175 | MP0000358_abnormal_cell_content/ | 0.49253254 |
| 176 | MP0005636_abnormal_mineral_homeostasis | 0.48531616 |
| 177 | MP0002734_abnormal_mechanical_nocicepti | 0.48204596 |
| 178 | MP0003119_abnormal_digestive_system | 0.47850315 |
| 179 | MP0003786_premature_aging | 0.46908749 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Congenital stationary night blindness (HP:0007642) | 5.84066198 |
| 2 | Oligomenorrhea (HP:0000876) | 5.49026066 |
| 3 | Rib fusion (HP:0000902) | 5.18729613 |
| 4 | Acanthosis nigricans (HP:0000956) | 4.92798968 |
| 5 | Hypertriglyceridemia (HP:0002155) | 4.78629675 |
| 6 | Attenuation of retinal blood vessels (HP:0007843) | 4.78148813 |
| 7 | Hyperglycinuria (HP:0003108) | 4.49316886 |
| 8 | Difficulty running (HP:0009046) | 4.26547420 |
| 9 | Multiple enchondromatosis (HP:0005701) | 4.26317449 |
| 10 | Increased connective tissue (HP:0009025) | 4.25827124 |
| 11 | Hypoplasia of the pons (HP:0012110) | 3.94432940 |
| 12 | Muscle fiber splitting (HP:0003555) | 3.91641951 |
| 13 | Poikiloderma (HP:0001029) | 3.87130767 |
| 14 | Abnormality of glycine metabolism (HP:0010895) | 3.76325995 |
| 15 | Abnormality of serine family amino acid metabolism (HP:0010894) | 3.76325995 |
| 16 | Abnormality of the heme biosynthetic pathway (HP:0010472) | 3.69066755 |
| 17 | Abnormality of the pons (HP:0007361) | 3.67914287 |
| 18 | Patellar aplasia (HP:0006443) | 3.67054092 |
| 19 | Myoglobinuria (HP:0002913) | 3.66794859 |
| 20 | Insulin-resistant diabetes mellitus (HP:0000831) | 3.61643178 |
| 21 | Myocardial infarction (HP:0001658) | 3.56014259 |
| 22 | Rhabdomyolysis (HP:0003201) | 3.54867659 |
| 23 | Chorioretinal atrophy (HP:0000533) | 3.54006267 |
| 24 | Polydipsia (HP:0001959) | 3.52628879 |
| 25 | Abnormal drinking behavior (HP:0030082) | 3.52628879 |
| 26 | Annular pancreas (HP:0001734) | 3.51477306 |
| 27 | Rectal fistula (HP:0100590) | 3.49217936 |
| 28 | Rectovaginal fistula (HP:0000143) | 3.49217936 |
| 29 | Aplasia/Hypoplasia of the patella (HP:0006498) | 3.47405524 |
| 30 | Bony spicule pigmentary retinopathy (HP:0007737) | 3.46303860 |
| 31 | Nausea (HP:0002018) | 3.44521679 |
| 32 | Intestinal fistula (HP:0100819) | 3.41050552 |
| 33 | Aplasia of the musculature (HP:0100854) | 3.40813203 |
| 34 | Tubular atrophy (HP:0000092) | 3.39049493 |
| 35 | Increased muscle lipid content (HP:0009058) | 3.36803595 |
| 36 | Autoimmune thrombocytopenia (HP:0001973) | 3.31943860 |
| 37 | Pendular nystagmus (HP:0012043) | 3.30110228 |
| 38 | Reduced subcutaneous adipose tissue (HP:0003758) | 3.29554641 |
| 39 | Aplasia/Hypoplasia involving the carpal bones (HP:0006502) | 3.29053290 |
| 40 | Absent thumb (HP:0009777) | 3.17962221 |
| 41 | Facial hemangioma (HP:0000329) | 3.09949050 |
| 42 | Short chin (HP:0000331) | 3.08851367 |
| 43 | Vaginal fistula (HP:0004320) | 3.05161116 |
| 44 | Popliteal pterygium (HP:0009756) | 3.00254427 |
| 45 | Type 1 muscle fiber predominance (HP:0003803) | 2.97717469 |
| 46 | Abnormality of fatty-acid metabolism (HP:0004359) | 2.95357488 |
| 47 | Testicular atrophy (HP:0000029) | 2.94698052 |
| 48 | Abnormality of long-chain fatty-acid metabolism (HP:0010964) | 2.90402869 |
| 49 | Nephronophthisis (HP:0000090) | 2.89541751 |
| 50 | Decreased circulating renin level (HP:0003351) | 2.86285404 |
| 51 | Type II lissencephaly (HP:0007260) | 2.85219914 |
| 52 | Fetal akinesia sequence (HP:0001989) | 2.84332936 |
| 53 | Squamous cell carcinoma (HP:0002860) | 2.84178118 |
| 54 | Polycythemia (HP:0001901) | 2.82951726 |
| 55 | Cerebellar dysplasia (HP:0007033) | 2.81109181 |
| 56 | Difficulty climbing stairs (HP:0003551) | 2.77972021 |
| 57 | Aplasia/Hypoplasia involving the musculature (HP:0001460) | 2.75531819 |
| 58 | Decreased subcutaneous fat (HP:0001002) | 2.74464924 |
| 59 | Abnormality of midbrain morphology (HP:0002418) | 2.73392806 |
| 60 | Molar tooth sign on MRI (HP:0002419) | 2.73392806 |
| 61 | Hypoalbuminemia (HP:0003073) | 2.71872658 |
| 62 | Abnormal albumin level (HP:0012116) | 2.71872658 |
| 63 | Ulnar bowing (HP:0003031) | 2.69925973 |
| 64 | Abnormality of dicarboxylic acid metabolism (HP:0010995) | 2.69034509 |
| 65 | Dicarboxylic aciduria (HP:0003215) | 2.69034509 |
| 66 | Akinesia (HP:0002304) | 2.68875681 |
| 67 | Polyuria (HP:0000103) | 2.65788706 |
| 68 | Thin bony cortex (HP:0002753) | 2.65018896 |
| 69 | Neck muscle weakness (HP:0000467) | 2.64801837 |
| 70 | Dyschromatopsia (HP:0007641) | 2.61610725 |
| 71 | Abnormality of homocysteine metabolism (HP:0010919) | 2.61545290 |
| 72 | Homocystinuria (HP:0002156) | 2.61545290 |
| 73 | Hyperglycinemia (HP:0002154) | 2.60827416 |
| 74 | Abnormal cartilage morphology (HP:0002763) | 2.59653416 |
| 75 | Premature rupture of membranes (HP:0001788) | 2.57716704 |
| 76 | Hydroxyprolinuria (HP:0003080) | 2.56632182 |
| 77 | Abnormality of proline metabolism (HP:0010907) | 2.56632182 |
| 78 | Pancreatic cysts (HP:0001737) | 2.55900954 |
| 79 | Decreased electroretinogram (ERG) amplitude (HP:0000654) | 2.52507836 |
| 80 | Cerebral aneurysm (HP:0004944) | 2.52361976 |
| 81 | Increased serum pyruvate (HP:0003542) | 2.52006804 |
| 82 | Abnormality of glycolysis (HP:0004366) | 2.52006804 |
| 83 | Abnormality of subcutaneous fat tissue (HP:0001001) | 2.48647705 |
| 84 | Decreased central vision (HP:0007663) | 2.45799534 |
| 85 | Axonal loss (HP:0003447) | 2.45631197 |
| 86 | Hypoalphalipoproteinemia (HP:0003233) | 2.44657298 |
| 87 | Bone cyst (HP:0012062) | 2.44509204 |
| 88 | Long foot (HP:0001833) | 2.43245711 |
| 89 | Increased serum ferritin (HP:0003281) | 2.42166339 |
| 90 | Coronal craniosynostosis (HP:0004440) | 2.37776594 |
| 91 | Abnormality of alanine metabolism (HP:0010916) | 2.37707339 |
| 92 | Hyperalaninemia (HP:0003348) | 2.37707339 |
| 93 | Abnormality of pyruvate family amino acid metabolism (HP:0010915) | 2.37707339 |
| 94 | Hemorrhage of the eye (HP:0011885) | 2.35134336 |
| 95 | Insulin resistance (HP:0000855) | 2.33123547 |
| 96 | Abnormality of the renal medulla (HP:0100957) | 2.32036466 |
| 97 | Hyporeflexia of lower limbs (HP:0002600) | 2.31535485 |
| 98 | Male infertility (HP:0003251) | 2.29440209 |
| 99 | Abnormal number of erythroid precursors (HP:0012131) | 2.27214951 |
| 100 | Tetraparesis (HP:0002273) | 2.26826968 |
| 101 | Hypophosphatemic rickets (HP:0004912) | 2.23595529 |
| 102 | Proximal amyotrophy (HP:0007126) | 2.23502619 |
| 103 | Increased variability in muscle fiber diameter (HP:0003557) | 2.22435040 |
| 104 | Growth hormone excess (HP:0000845) | 2.20680473 |
| 105 | Stridor (HP:0010307) | 2.20441088 |
| 106 | Decreased activity of cytochrome C oxidase in muscle tissue (HP:0003688) | 2.20437590 |
| 107 | Diaphragmatic weakness (HP:0009113) | 2.19440271 |
| 108 | Increased number of teeth (HP:0011069) | 2.17519981 |
| 109 | Chronic hepatic failure (HP:0100626) | 2.15742040 |
| 110 | Abnormal urine output (HP:0012590) | 2.14990035 |
| 111 | Reduced antithrombin III activity (HP:0001976) | 2.14833406 |
| 112 | Hypoglycemic coma (HP:0001325) | 2.14007095 |
| 113 | Ileus (HP:0002595) | 2.12861157 |
| 114 | Neonatal respiratory distress (HP:0002643) | 2.12530407 |
| 115 | Increased IgM level (HP:0003496) | 2.12072642 |
| 116 | Type 2 muscle fiber atrophy (HP:0003554) | 2.09320469 |
| 117 | Facial diplegia (HP:0001349) | 2.09236381 |
| 118 | Progressive muscle weakness (HP:0003323) | 2.08254821 |
| 119 | Genetic anticipation (HP:0003743) | 2.07647330 |
| 120 | Brushfield spots (HP:0001088) | 2.07645663 |
| 121 | Reticulocytosis (HP:0001923) | 2.07418292 |
| 122 | Methylmalonic aciduria (HP:0012120) | 2.06119535 |
| 123 | Ketoacidosis (HP:0001993) | 2.05069450 |
| 124 | Hand muscle atrophy (HP:0009130) | 2.04233428 |
| 125 | Short thumb (HP:0009778) | 2.03696023 |
| 126 | Osteolytic defects of the phalanges of the hand (HP:0009771) | 2.02948017 |
| 127 | Osteolytic defects of the hand bones (HP:0009699) | 2.02948017 |
| 128 | Enlarged epiphyses (HP:0010580) | 2.02329444 |
| 129 | Ketosis (HP:0001946) | 2.02091024 |
| 130 | Distal upper limb amyotrophy (HP:0007149) | 2.01075215 |
| 131 | Upper limb amyotrophy (HP:0009129) | 2.01075215 |
| 132 | Myotonia (HP:0002486) | 2.00873749 |
| 133 | Premature graying of hair (HP:0002216) | 1.99635474 |
| 134 | Pancreatic fibrosis (HP:0100732) | 1.98907697 |
| 135 | Dynein arm defect of respiratory motile cilia (HP:0012255) | 1.98405647 |
| 136 | Absent/shortened dynein arms (HP:0200106) | 1.98405647 |
| 137 | Birth length less than 3rd percentile (HP:0003561) | 1.98103061 |
| 138 | Delayed epiphyseal ossification (HP:0002663) | 1.97202453 |
| 139 | Capillary hemangiomas (HP:0005306) | 1.96631454 |
| 140 | Abnormality of DNA repair (HP:0003254) | 1.96528119 |
| 141 | Abnormal protein N-linked glycosylation (HP:0012347) | 1.96464159 |
| 142 | Abnormal protein glycosylation (HP:0012346) | 1.96464159 |
| 143 | Abnormal glycosylation (HP:0012345) | 1.96464159 |
| 144 | Abnormal isoelectric focusing of serum transferrin (HP:0003160) | 1.96464159 |
| 145 | Duplicated collecting system (HP:0000081) | 1.95563924 |
| 146 | Lipoatrophy (HP:0100578) | 1.95259024 |
| 147 | Ankle contracture (HP:0006466) | 1.95190176 |
| 148 | Clumsiness (HP:0002312) | 1.94870308 |
| 149 | Poikilocytosis (HP:0004447) | 1.94527190 |
| 150 | Amniotic constriction ring (HP:0009775) | 1.93902595 |
| 151 | Abnormality of placental membranes (HP:0011409) | 1.93902595 |
| 152 | Type I transferrin isoform profile (HP:0003642) | 1.93545607 |
| 153 | Segmental peripheral demyelination/remyelination (HP:0003481) | 1.92325749 |
| 154 | Bowing of the arm (HP:0006488) | 1.92324283 |
| 155 | Bowed forearm bones (HP:0003956) | 1.92324283 |
| 156 | Abnormality of skeletal muscle fiber size (HP:0012084) | 1.91983488 |
| 157 | Abnormality of the renal collecting system (HP:0004742) | 1.90961805 |
| 158 | Abnormality of the costochondral junction (HP:0000919) | 1.89428403 |
| 159 | Large hands (HP:0001176) | 1.89080099 |
| 160 | Absent radius (HP:0003974) | 1.88394676 |
| 161 | Abnormality of the intrinsic pathway (HP:0010989) | 1.88256804 |
| 162 | Progressive microcephaly (HP:0000253) | 1.88167931 |
| 163 | Mesangial abnormality (HP:0001966) | 1.87739886 |
| 164 | Severe muscular hypotonia (HP:0006829) | 1.87141992 |
| 165 | Achilles tendon contracture (HP:0001771) | 1.86323075 |
| 166 | Fasciculations (HP:0002380) | 1.85808202 |
| 167 | Myopathic facies (HP:0002058) | 1.85581872 |
| 168 | Turricephaly (HP:0000262) | 1.84909740 |
| 169 | Tachypnea (HP:0002789) | 1.84729031 |
| 170 | Infertility (HP:0000789) | 1.84371013 |
| 171 | Exercise-induced myalgia (HP:0003738) | 1.84042218 |
| 172 | Nemaline bodies (HP:0003798) | 1.81604540 |
| 173 | Paralysis (HP:0003470) | 1.81539887 |
| 174 | Spinal rigidity (HP:0003306) | 1.80991079 |
| 175 | Slender build (HP:0001533) | 1.80980609 |
| 176 | Muscle fiber cytoplasmatic inclusion bodies (HP:0100303) | 1.80722452 |
| 177 | Muscle fiber inclusion bodies (HP:0100299) | 1.80494966 |
| 178 | Hyperammonemia (HP:0001987) | 1.80363933 |
| 179 | Abnormal hemoglobin (HP:0011902) | 1.80007240 |
| 180 | Hyperlipoproteinemia (HP:0010980) | 1.78092986 |
| 181 | Xanthomatosis (HP:0000991) | 1.77983038 |
| 182 | Abnormality of iron homeostasis (HP:0011031) | 1.76644502 |
| 183 | Pancreatitis (HP:0001733) | 1.75502636 |
| 184 | Cortical dysplasia (HP:0002539) | 1.74317745 |
| 185 | Cholelithiasis (HP:0001081) | 1.72584939 |
| 186 | Personality changes (HP:0000751) | 1.71893682 |
| 187 | Hepatic necrosis (HP:0002605) | 1.71320386 |
| 188 | Vertebral compression fractures (HP:0002953) | 1.69569404 |
| 189 | Pustule (HP:0200039) | 1.69339466 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | CAMK1D | 5.51782974 |
| 2 | TRIB3 | 5.27234601 |
| 3 | MAPK15 | 5.07580071 |
| 4 | WNK4 | 4.96684877 |
| 5 | BCKDK | 4.55879034 |
| 6 | FRK | 3.71907143 |
| 7 | CAMK1G | 3.58181315 |
| 8 | ADRBK2 | 3.20162926 |
| 9 | SIK1 | 2.80413877 |
| 10 | MUSK | 2.62840253 |
| 11 | EIF2AK1 | 2.58540369 |
| 12 | ERN1 | 2.33918972 |
| 13 | BMPR1B | 2.17669910 |
| 14 | DAPK2 | 2.10516540 |
| 15 | PRKAA2 | 2.07435613 |
| 16 | PDK3 | 2.00802248 |
| 17 | PDK4 | 2.00802248 |
| 18 | GRK1 | 2.00242846 |
| 19 | GRK6 | 1.98736415 |
| 20 | NME2 | 1.95573932 |
| 21 | SCYL2 | 1.90821406 |
| 22 | RIPK1 | 1.77556496 |
| 23 | TYK2 | 1.74816000 |
| 24 | ADRBK1 | 1.64497488 |
| 25 | PKN2 | 1.63993517 |
| 26 | PIM2 | 1.55924113 |
| 27 | MAP2K6 | 1.54241630 |
| 28 | PDK2 | 1.49512551 |
| 29 | TAOK3 | 1.43252158 |
| 30 | JAK2 | 1.34493534 |
| 31 | MAP3K11 | 1.34395785 |
| 32 | PINK1 | 1.31370916 |
| 33 | JAK3 | 1.29388275 |
| 34 | CDK6 | 1.29064044 |
| 35 | STK16 | 1.27507409 |
| 36 | LMTK2 | 1.21510059 |
| 37 | TXK | 1.20985691 |
| 38 | MAPKAPK3 | 1.20871373 |
| 39 | TESK2 | 1.19070304 |
| 40 | MAP3K6 | 1.18911460 |
| 41 | BUB1 | 1.17534749 |
| 42 | JAK1 | 1.16689264 |
| 43 | IKBKB | 1.15453123 |
| 44 | SIK2 | 1.13635775 |
| 45 | MAP2K1 | 1.13607324 |
| 46 | TBK1 | 1.10429598 |
| 47 | WNK1 | 1.09996366 |
| 48 | PRKCI | 1.08999989 |
| 49 | OXSR1 | 1.08315098 |
| 50 | BCR | 1.07362123 |
| 51 | MAPK13 | 1.06799057 |
| 52 | STK39 | 1.05377694 |
| 53 | KDR | 1.05141088 |
| 54 | LATS2 | 1.04937442 |
| 55 | PRKAA1 | 1.04767976 |
| 56 | TTN | 1.02393573 |
| 57 | KSR2 | 0.96779574 |
| 58 | INSRR | 0.96540051 |
| 59 | MAPK11 | 0.96538636 |
| 60 | OBSCN | 0.96275229 |
| 61 | BMX | 0.95093766 |
| 62 | CDK12 | 0.93076026 |
| 63 | ARAF | 0.92943257 |
| 64 | MAP2K2 | 0.85869420 |
| 65 | MTOR | 0.85712032 |
| 66 | MAP4K1 | 0.84616638 |
| 67 | PHKG2 | 0.82588424 |
| 68 | PHKG1 | 0.82588424 |
| 69 | RPS6KA5 | 0.82492135 |
| 70 | PDGFRA | 0.81277490 |
| 71 | FGFR4 | 0.81155746 |
| 72 | RPS6KA6 | 0.80940740 |
| 73 | ABL2 | 0.78939884 |
| 74 | CDK4 | 0.77690283 |
| 75 | MAPKAPK5 | 0.76779350 |
| 76 | NUAK1 | 0.76238386 |
| 77 | MAP4K2 | 0.76113604 |
| 78 | MAP3K14 | 0.75961291 |
| 79 | STK11 | 0.74576881 |
| 80 | CHEK2 | 0.73947705 |
| 81 | PRKD2 | 0.72529885 |
| 82 | NEK9 | 0.72333510 |
| 83 | DDR2 | 0.71655725 |
| 84 | TRPM7 | 0.71201582 |
| 85 | MAPK12 | 0.69999132 |
| 86 | MARK2 | 0.68553255 |
| 87 | EIF2AK2 | 0.66862653 |
| 88 | PDPK1 | 0.66560606 |
| 89 | CDK9 | 0.64534555 |
| 90 | MAP2K3 | 0.64306206 |
| 91 | PTK2B | 0.62431240 |
| 92 | ATR | 0.61258898 |
| 93 | RET | 0.61129858 |
| 94 | MAP3K7 | 0.60782003 |
| 95 | PIM1 | 0.59793883 |
| 96 | NEK2 | 0.59539024 |
| 97 | TGFBR2 | 0.58998883 |
| 98 | PRKCQ | 0.58122212 |
| 99 | PRKACG | 0.57764326 |
| 100 | EPHB1 | 0.57386578 |
| 101 | MELK | 0.57284870 |
| 102 | ACVR1B | 0.56975345 |
| 103 | ZAP70 | 0.56506208 |
| 104 | CAMK1 | 0.56334256 |
| 105 | MAP3K8 | 0.55272043 |
| 106 | CSNK1D | 0.54611496 |
| 107 | RPS6KA2 | 0.52950890 |
| 108 | STK3 | 0.52925681 |
| 109 | GSK3A | 0.52726706 |
| 110 | CAMKK1 | 0.51900126 |
| 111 | FLT3 | 0.51450019 |
| 112 | PKN1 | 0.50707789 |
| 113 | STK4 | 0.50509560 |
| 114 | MST1R | 0.50446607 |
| 115 | PRKCH | 0.49570511 |
| 116 | HIPK2 | 0.49553900 |
| 117 | EPHB2 | 0.48021491 |
| 118 | EIF2AK3 | 0.47584874 |
| 119 | CHUK | 0.46606240 |
| 120 | MAPK8 | 0.45100789 |
| 121 | FGR | 0.44696677 |
| 122 | PRKD1 | 0.44649767 |
| 123 | LATS1 | 0.44121318 |
| 124 | LRRK2 | 0.43931474 |
| 125 | PRKCG | 0.42114805 |
| 126 | ZAK | 0.41989967 |
| 127 | RPS6KC1 | 0.41408168 |
| 128 | RPS6KL1 | 0.41408168 |
| 129 | CDK8 | 0.40430435 |
| 130 | ILK | 0.40428235 |
| 131 | MAP3K9 | 0.40284721 |
| 132 | IKBKE | 0.39919107 |
| 133 | PDGFRB | 0.39877959 |
| 134 | DYRK3 | 0.38985594 |
| 135 | DYRK2 | 0.38975819 |
| 136 | PDK1 | 0.38872750 |
| 137 | TIE1 | 0.38278358 |
| 138 | MAP2K4 | 0.38110186 |
| 139 | DAPK3 | 0.38029787 |
| 140 | CSK | 0.37191079 |
| 141 | BLK | 0.36883474 |
| 142 | FGFR3 | 0.36138728 |
| 143 | MAP3K13 | 0.35584249 |
| 144 | TLK1 | 0.35046236 |
| 145 | CAMKK2 | 0.35022724 |
| 146 | MET | 0.34849609 |
| 147 | AURKA | 0.34207339 |
| 148 | MAPKAPK2 | 0.33885240 |
| 149 | MAP3K5 | 0.33748308 |
| 150 | SYK | 0.33618581 |
| 151 | TGFBR1 | 0.33399715 |
| 152 | EEF2K | 0.33324663 |
| 153 | AKT3 | 0.33300545 |
| 154 | RPS6KB2 | 0.33261820 |
| 155 | MOS | 0.33241337 |
| 156 | RAF1 | 0.33191728 |
| 157 | INSR | 0.33125797 |
| 158 | NTRK3 | 0.32022075 |
| 159 | PRKACA | 0.29467210 |
| 160 | WNK3 | 0.28755163 |
| 161 | ITK | 0.26702433 |
| 162 | GRK5 | 0.24013565 |
| 163 | TNK2 | 0.23635046 |
| 164 | SGK223 | 0.21426394 |
| 165 | SGK494 | 0.21426394 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Glycosphingolipid biosynthesis - ganglio series_Homo sapiens_hsa00604 | 6.13625258 |
| 2 | Fatty acid biosynthesis_Homo sapiens_hsa00061 | 5.76220850 |
| 3 | Propanoate metabolism_Homo sapiens_hsa00640 | 4.12601881 |
| 4 | Citrate cycle (TCA cycle)_Homo sapiens_hsa00020 | 3.68768969 |
| 5 | Glycosphingolipid biosynthesis - globo series_Homo sapiens_hsa00603 | 3.60414404 |
| 6 | Regulation of lipolysis in adipocytes_Homo sapiens_hsa04923 | 3.44487098 |
| 7 | PPAR signaling pathway_Homo sapiens_hsa03320 | 3.35052862 |
| 8 | Fatty acid metabolism_Homo sapiens_hsa01212 | 3.30951492 |
| 9 | Valine, leucine and isoleucine degradation_Homo sapiens_hsa00280 | 3.25842296 |
| 10 | Ubiquinone and other terpenoid-quinone biosynthesis_Homo sapiens_hsa00130 | 3.21216080 |
| 11 | 2-Oxocarboxylic acid metabolism_Homo sapiens_hsa01210 | 3.14114291 |
| 12 | Glycerolipid metabolism_Homo sapiens_hsa00561 | 2.62192228 |
| 13 | Glycosylphosphatidylinositol(GPI)-anchor biosynthesis_Homo sapiens_hsa00563 | 2.52793101 |
| 14 | Vitamin B6 metabolism_Homo sapiens_hsa00750 | 2.36577401 |
| 15 | Adipocytokine signaling pathway_Homo sapiens_hsa04920 | 2.22951669 |
| 16 | Fatty acid degradation_Homo sapiens_hsa00071 | 2.13156377 |
| 17 | Fanconi anemia pathway_Homo sapiens_hsa03460 | 2.11581641 |
| 18 | Neuroactive ligand-receptor interaction_Homo sapiens_hsa04080 | 2.09823328 |
| 19 | Pyruvate metabolism_Homo sapiens_hsa00620 | 2.08620127 |
| 20 | AMPK signaling pathway_Homo sapiens_hsa04152 | 1.99477850 |
| 21 | Nicotine addiction_Homo sapiens_hsa05033 | 1.89428389 |
| 22 | Fat digestion and absorption_Homo sapiens_hsa04975 | 1.87980342 |
| 23 | Phototransduction_Homo sapiens_hsa04744 | 1.84908199 |
| 24 | Glyoxylate and dicarboxylate metabolism_Homo sapiens_hsa00630 | 1.79138022 |
| 25 | Taste transduction_Homo sapiens_hsa04742 | 1.77779741 |
| 26 | Nitrogen metabolism_Homo sapiens_hsa00910 | 1.76979739 |
| 27 | Carbon metabolism_Homo sapiens_hsa01200 | 1.76906221 |
| 28 | Selenocompound metabolism_Homo sapiens_hsa00450 | 1.70302066 |
| 29 | Sulfur relay system_Homo sapiens_hsa04122 | 1.67112818 |
| 30 | Caffeine metabolism_Homo sapiens_hsa00232 | 1.64257586 |
| 31 | Homologous recombination_Homo sapiens_hsa03440 | 1.60781464 |
| 32 | Glycosphingolipid biosynthesis - lacto and neolacto series_Homo sapiens_hsa00601 | 1.48506551 |
| 33 | Circadian rhythm_Homo sapiens_hsa04710 | 1.48380846 |
| 34 | Non-alcoholic fatty liver disease (NAFLD)_Homo sapiens_hsa04932 | 1.47243346 |
| 35 | Other types of O-glycan biosynthesis_Homo sapiens_hsa00514 | 1.43509453 |
| 36 | Terpenoid backbone biosynthesis_Homo sapiens_hsa00900 | 1.40429698 |
| 37 | Mucin type O-Glycan biosynthesis_Homo sapiens_hsa00512 | 1.37823405 |
| 38 | One carbon pool by folate_Homo sapiens_hsa00670 | 1.35759990 |
| 39 | Autoimmune thyroid disease_Homo sapiens_hsa05320 | 1.31463119 |
| 40 | Pentose phosphate pathway_Homo sapiens_hsa00030 | 1.28180756 |
| 41 | Calcium signaling pathway_Homo sapiens_hsa04020 | 1.23332685 |
| 42 | Basal transcription factors_Homo sapiens_hsa03022 | 1.22080073 |
| 43 | Porphyrin and chlorophyll metabolism_Homo sapiens_hsa00860 | 1.16785748 |
| 44 | Vitamin digestion and absorption_Homo sapiens_hsa04977 | 1.14970505 |
| 45 | Glycosaminoglycan degradation_Homo sapiens_hsa00531 | 1.10963963 |
| 46 | Insulin signaling pathway_Homo sapiens_hsa04910 | 1.10355547 |
| 47 | Glycerophospholipid metabolism_Homo sapiens_hsa00564 | 1.07988389 |
| 48 | Insulin resistance_Homo sapiens_hsa04931 | 1.07588413 |
| 49 | Peroxisome_Homo sapiens_hsa04146 | 1.04216138 |
| 50 | Tryptophan metabolism_Homo sapiens_hsa00380 | 1.03434723 |
| 51 | beta-Alanine metabolism_Homo sapiens_hsa00410 | 1.03113121 |
| 52 | Folate biosynthesis_Homo sapiens_hsa00790 | 1.00382654 |
| 53 | Proteasome_Homo sapiens_hsa03050 | 0.99666858 |
| 54 | Graft-versus-host disease_Homo sapiens_hsa05332 | 0.99603653 |
| 55 | Ovarian steroidogenesis_Homo sapiens_hsa04913 | 0.99518905 |
| 56 | Amino sugar and nucleotide sugar metabolism_Homo sapiens_hsa00520 | 0.98323360 |
| 57 | Lysine degradation_Homo sapiens_hsa00310 | 0.97603932 |
| 58 | Longevity regulating pathway - mammal_Homo sapiens_hsa04211 | 0.94836571 |
| 59 | Maturity onset diabetes of the young_Homo sapiens_hsa04950 | 0.94650708 |
| 60 | Sphingolipid metabolism_Homo sapiens_hsa00600 | 0.93714610 |
| 61 | Morphine addiction_Homo sapiens_hsa05032 | 0.91515275 |
| 62 | Biosynthesis of amino acids_Homo sapiens_hsa01230 | 0.86484545 |
| 63 | Hedgehog signaling pathway_Homo sapiens_hsa04340 | 0.83273121 |
| 64 | Ether lipid metabolism_Homo sapiens_hsa00565 | 0.80718203 |
| 65 | Allograft rejection_Homo sapiens_hsa05330 | 0.79807723 |
| 66 | Viral myocarditis_Homo sapiens_hsa05416 | 0.78723658 |
| 67 | Pyrimidine metabolism_Homo sapiens_hsa00240 | 0.78679667 |
| 68 | Cyanoamino acid metabolism_Homo sapiens_hsa00460 | 0.77522384 |
| 69 | Carbohydrate digestion and absorption_Homo sapiens_hsa04973 | 0.77463805 |
| 70 | Glycine, serine and threonine metabolism_Homo sapiens_hsa00260 | 0.76686434 |
| 71 | Lysosome_Homo sapiens_hsa04142 | 0.75123887 |
| 72 | Cytosolic DNA-sensing pathway_Homo sapiens_hsa04623 | 0.71526903 |
| 73 | Apoptosis_Homo sapiens_hsa04210 | 0.70489371 |
| 74 | Fatty acid elongation_Homo sapiens_hsa00062 | 0.68926981 |
| 75 | Butanoate metabolism_Homo sapiens_hsa00650 | 0.68673874 |
| 76 | Legionellosis_Homo sapiens_hsa05134 | 0.66584105 |
| 77 | Primary immunodeficiency_Homo sapiens_hsa05340 | 0.66067719 |
| 78 | Olfactory transduction_Homo sapiens_hsa04740 | 0.65673435 |
| 79 | Circadian entrainment_Homo sapiens_hsa04713 | 0.64713255 |
| 80 | Toxoplasmosis_Homo sapiens_hsa05145 | 0.64124872 |
| 81 | Purine metabolism_Homo sapiens_hsa00230 | 0.63568445 |
| 82 | Insulin secretion_Homo sapiens_hsa04911 | 0.62999208 |
| 83 | Alcoholism_Homo sapiens_hsa05034 | 0.60436979 |
| 84 | Staphylococcus aureus infection_Homo sapiens_hsa05150 | 0.58224011 |
| 85 | Toll-like receptor signaling pathway_Homo sapiens_hsa04620 | 0.56743014 |
| 86 | Parkinsons disease_Homo sapiens_hsa05012 | 0.55209890 |
| 87 | Pantothenate and CoA biosynthesis_Homo sapiens_hsa00770 | 0.55168972 |
| 88 | Acute myeloid leukemia_Homo sapiens_hsa05221 | 0.54861511 |
| 89 | Cardiac muscle contraction_Homo sapiens_hsa04260 | 0.54671957 |
| 90 | Chemical carcinogenesis_Homo sapiens_hsa05204 | 0.54055042 |
| 91 | Malaria_Homo sapiens_hsa05144 | 0.53261897 |
| 92 | Glutamatergic synapse_Homo sapiens_hsa04724 | 0.52923282 |
| 93 | Proximal tubule bicarbonate reclamation_Homo sapiens_hsa04964 | 0.52588809 |
| 94 | Salivary secretion_Homo sapiens_hsa04970 | 0.52488314 |
| 95 | alpha-Linolenic acid metabolism_Homo sapiens_hsa00592 | 0.52214570 |
| 96 | Phenylalanine metabolism_Homo sapiens_hsa00360 | 0.51495538 |
| 97 | p53 signaling pathway_Homo sapiens_hsa04115 | 0.50688282 |
| 98 | HIF-1 signaling pathway_Homo sapiens_hsa04066 | 0.50287758 |
| 99 | Taurine and hypotaurine metabolism_Homo sapiens_hsa00430 | 0.50038675 |
| 100 | Histidine metabolism_Homo sapiens_hsa00340 | 0.48728476 |
| 101 | Small cell lung cancer_Homo sapiens_hsa05222 | 0.47566110 |
| 102 | Measles_Homo sapiens_hsa05162 | 0.47303710 |
| 103 | Protein digestion and absorption_Homo sapiens_hsa04974 | 0.47035804 |
| 104 | Systemic lupus erythematosus_Homo sapiens_hsa05322 | 0.46805941 |
| 105 | Aldosterone synthesis and secretion_Homo sapiens_hsa04925 | 0.46511931 |
| 106 | Regulation of autophagy_Homo sapiens_hsa04140 | 0.43907510 |
| 107 | Retrograde endocannabinoid signaling_Homo sapiens_hsa04723 | 0.43802349 |
| 108 | Herpes simplex infection_Homo sapiens_hsa05168 | 0.43422027 |
| 109 | Hippo signaling pathway_Homo sapiens_hsa04390 | 0.41799021 |
| 110 | Cholinergic synapse_Homo sapiens_hsa04725 | 0.40167744 |
| 111 | cAMP signaling pathway_Homo sapiens_hsa04024 | 0.39449947 |
| 112 | mTOR signaling pathway_Homo sapiens_hsa04150 | 0.38776476 |
| 113 | Jak-STAT signaling pathway_Homo sapiens_hsa04630 | 0.38720496 |
| 114 | Oxytocin signaling pathway_Homo sapiens_hsa04921 | 0.38446571 |
| 115 | Fc gamma R-mediated phagocytosis_Homo sapiens_hsa04666 | 0.38192275 |
| 116 | Vascular smooth muscle contraction_Homo sapiens_hsa04270 | 0.38030848 |
| 117 | Influenza A_Homo sapiens_hsa05164 | 0.37404095 |
| 118 | RNA degradation_Homo sapiens_hsa03018 | 0.37361231 |
| 119 | VEGF signaling pathway_Homo sapiens_hsa04370 | 0.37235102 |
| 120 | Fructose and mannose metabolism_Homo sapiens_hsa00051 | 0.36781315 |
| 121 | Synthesis and degradation of ketone bodies_Homo sapiens_hsa00072 | 0.36707264 |
| 122 | Oxidative phosphorylation_Homo sapiens_hsa00190 | 0.36322104 |
| 123 | Shigellosis_Homo sapiens_hsa05131 | 0.34815784 |
| 124 | RIG-I-like receptor signaling pathway_Homo sapiens_hsa04622 | 0.32898431 |
| 125 | Leishmaniasis_Homo sapiens_hsa05140 | 0.32892456 |
| 126 | Basal cell carcinoma_Homo sapiens_hsa05217 | 0.32615996 |
| 127 | Cocaine addiction_Homo sapiens_hsa05030 | 0.32510321 |
| 128 | Sulfur metabolism_Homo sapiens_hsa00920 | 0.32053354 |
| 129 | Nicotinate and nicotinamide metabolism_Homo sapiens_hsa00760 | 0.31869888 |
| 130 | Linoleic acid metabolism_Homo sapiens_hsa00591 | 0.31705350 |
| 131 | Tuberculosis_Homo sapiens_hsa05152 | 0.31228122 |
| 132 | Hepatitis C_Homo sapiens_hsa05160 | 0.30688333 |
| 133 | MAPK signaling pathway_Homo sapiens_hsa04010 | 0.30309879 |
| 134 | Chronic myeloid leukemia_Homo sapiens_hsa05220 | 0.30250290 |
| 135 | Glycosaminoglycan biosynthesis - keratan sulfate_Homo sapiens_hsa00533 | 0.29298579 |
| 136 | Alzheimers disease_Homo sapiens_hsa05010 | 0.28923184 |
| 137 | Sphingolipid signaling pathway_Homo sapiens_hsa04071 | 0.28705061 |
| 138 | Bacterial invasion of epithelial cells_Homo sapiens_hsa05100 | 0.28695764 |
| 139 | Epstein-Barr virus infection_Homo sapiens_hsa05169 | 0.28138626 |
| 140 | Steroid hormone biosynthesis_Homo sapiens_hsa00140 | 0.27071662 |
| 141 | Osteoclast differentiation_Homo sapiens_hsa04380 | 0.27052044 |
| 142 | Intestinal immune network for IgA production_Homo sapiens_hsa04672 | 0.27042999 |
| 143 | NOD-like receptor signaling pathway_Homo sapiens_hsa04621 | 0.25914455 |
| 144 | Nucleotide excision repair_Homo sapiens_hsa03420 | 0.25694395 |
| 145 | Serotonergic synapse_Homo sapiens_hsa04726 | 0.25591357 |
| 146 | NF-kappa B signaling pathway_Homo sapiens_hsa04064 | 0.25574731 |
| 147 | N-Glycan biosynthesis_Homo sapiens_hsa00510 | 0.25467436 |
| 148 | GABAergic synapse_Homo sapiens_hsa04727 | 0.25462989 |
| 149 | Drug metabolism - cytochrome P450_Homo sapiens_hsa00982 | 0.25393150 |
| 150 | Metabolic pathways_Homo sapiens_hsa01100 | 0.25048758 |
| 151 | Thyroid cancer_Homo sapiens_hsa05216 | 0.24756411 |
| 152 | Type II diabetes mellitus_Homo sapiens_hsa04930 | 0.24680386 |
| 153 | Mineral absorption_Homo sapiens_hsa04978 | 0.24503529 |
| 154 | Progesterone-mediated oocyte maturation_Homo sapiens_hsa04914 | 0.24429766 |
| 155 | Ribosome biogenesis in eukaryotes_Homo sapiens_hsa03008 | 0.23142585 |
| 156 | Hepatitis B_Homo sapiens_hsa05161 | 0.22401602 |
| 157 | Longevity regulating pathway - multiple species_Homo sapiens_hsa04213 | 0.22334973 |
| 158 | Central carbon metabolism in cancer_Homo sapiens_hsa05230 | 0.22293156 |
| 159 | Renin-angiotensin system_Homo sapiens_hsa04614 | 0.21611751 |
| 160 | Huntingtons disease_Homo sapiens_hsa05016 | 0.21233487 |
| 161 | Base excision repair_Homo sapiens_hsa03410 | 0.20434082 |
| 162 | Endocytosis_Homo sapiens_hsa04144 | 0.20086471 |
| 163 | AGE-RAGE signaling pathway in diabetic complications_Homo sapiens_hsa04933 | 0.18704957 |
| 164 | RNA polymerase_Homo sapiens_hsa03020 | 0.18350968 |
| 165 | Glucagon signaling pathway_Homo sapiens_hsa04922 | 0.17636666 |
| 166 | FoxO signaling pathway_Homo sapiens_hsa04068 | 0.17523959 |
| 167 | ABC transporters_Homo sapiens_hsa02010 | 0.17324461 |

